These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11932297)

  • 1. Supraphysiological doses of GH induce rapid changes in cardiac morphology and function.
    Cittadini A; Berggren A; Longobardi S; Ehrnborg C; Napoli R; Rosén T; Fazio S; Caidahl K; Bengtsson BA; Saccà L
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1654-9. PubMed ID: 11932297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
    Hartgens F; Cheriex EC; Kuipers H
    Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.
    Newman CB; Frisch KA; Rosenzweig B; Roubenoff R; Rey M; Kidder T; Kong Y; Pursnani A; Sedlis SP; Schwartzbard A; Kleinberg DL
    J Clin Endocrinol Metab; 2011 Jan; 96(1):122-32. PubMed ID: 20926529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.
    Ezzat S; Fear S; Gaillard RC; Gayle C; Landy H; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2725-33. PubMed ID: 12050241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.
    Berggren A; Ehrnborg C; Rosén T; Ellegård L; Bengtsson BA; Caidahl K
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3268-73. PubMed ID: 15784718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of growth hormone.
    Caidahl K; Edén S; Bengtsson BA
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):393-400. PubMed ID: 8187304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
    Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation.
    Cittadini A; Strömer H; Katz SE; Clark R; Moses AC; Morgan JP; Douglas PS
    Circulation; 1996 Feb; 93(4):800-9. PubMed ID: 8641010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis.
    Maison P; Chanson P
    Circulation; 2003 Nov; 108(21):2648-52. PubMed ID: 14623813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults.
    Yuen K; Frystyk J; Umpleby M; Fryklund L; Dunger D
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3956-64. PubMed ID: 15292333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats.
    Longobardi S; Cittadini A; Strömer H; Katz SE; Grossman JD; Clark RG; Morgan JP; Douglas PS
    Growth Horm IGF Res; 2000 Oct; 10(5):242-7. PubMed ID: 11042020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency.
    Shulman DI; Root AW; Diamond FB; Bercu BB; Martinez R; Boucek RJ
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4095-9. PubMed ID: 12970269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.
    Yuen K; Ong K; Husbands S; Chatelain P; Fryklund L; Gluckman P; Ranke M; Cook D; Rosenfeld R; Wass J; Dunger D
    J Clin Endocrinol Metab; 2002 May; 87(5):1989-95. PubMed ID: 11994330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients.
    Johannsson G; Bengtsson BA; Andersson B; Isgaard J; Caidahl K
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):305-14. PubMed ID: 8949568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment.
    Jensen PB; Ekelund B; Nielsen FT; Baumbach L; Pedersen FB; Oxhøj H
    Clin Nephrol; 2000 Jan; 53(1):25-32. PubMed ID: 10661479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.
    Böger RH; Skamira C; Bode-Böger SM; Brabant G; von zur Muhlen A; Frolich JC
    J Clin Invest; 1996 Dec; 98(12):2706-13. PubMed ID: 8981915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.